NADPH oxidase p22phox and catalase gene variants are associated with biomarkers of oxidative stress and adverse outcomes in acute renal failure.
暂无分享,去创建一个
B. Jaber | J. Bonventre | M. Perianayagam | B. Pereira | V. Balakrishnan | Lijun Li | R. Wald | O. Liangos | A. Kolyada | Madhumati Rao | Robert W MacKinnon
[1] Tom Greene,et al. Assessing kidney function--measured and estimated glomerular filtration rate. , 2006, The New England journal of medicine.
[2] R. Ferrell,et al. NADPH oxidase p22phox gene variants are associated with systemic oxidative stress biomarker responses to exercise training. , 2005, Journal of applied physiology.
[3] L. Price,et al. Epidemiology and outcomes of acute renal failure in hospitalized patients: a national survey. , 2005, Clinical journal of the American Society of Nephrology : CJASN.
[4] K. Tokunaga,et al. Haplotype analysis of NAD(P)H oxidase p22 phox polymorphisms in end-stage renal disease , 2005, Journal of Human Genetics.
[5] R. de Caterina,et al. Oxidative stress and cardiovascular risk: the role of vascular NAD(P)H oxidase and its genetic variants , 2005, European journal of clinical investigation.
[6] R. Atkins. The epidemiology of chronic kidney disease. , 2005, Kidney international. Supplement.
[7] J. Bertrand,et al. Association of CAT polymorphisms with catalase activity and exposure to environmental oxidative stimuli , 2005, Free radical research.
[8] Jonathan Himmelfarb,et al. Spectrum of acute renal failure in the intensive care unit: the PICARD experience. , 2004, Kidney international.
[9] Y. Ho,et al. Mice Lacking Catalase Develop Normally but Show Differential Sensitivity to Oxidant Tissue Injury* , 2004, Journal of Biological Chemistry.
[10] M. Goligorsky,et al. NO bioavailability, endothelial dysfunction, and acute renal failure: new insights into pathophysiology. , 2004, Seminars in nephrology.
[11] D. Harrison,et al. C242T CYBA Polymorphism of the NADPH Oxidase Is Associated With Reduced Respiratory Burst in Human Neutrophils , 2004, Hypertension.
[12] R. Turakulov,et al. A new type 1 diabetes susceptibility locus containing the catalase gene (chromosome 11p13) in a Russian population , 2004, Diabetes/metabolism research and reviews.
[13] B. Jaber,et al. Cytokine gene promoter polymorphisms and mortality in acute renal failure. , 2004, Cytokine.
[14] A. Demaine,et al. Association of the p22phox component of NAD(P)H oxidase with susceptibility to diabetic nephropathy in patients with type 1 diabetes. , 2003, Diabetes care.
[15] T. Maruyama,et al. NAD(P)H oxidase p22phox Gene C242T polymorphism and lipoprotein oxidation. , 2003, Clinica chimica acta; international journal of clinical chemistry.
[16] N. Webster,et al. Oxidative stress and gene expression in sepsis. , 2003, British journal of anaesthesia.
[17] R. Poveda,et al. Goodpasture syndrome during the course of a Schönlein-Henoch purpura. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[18] S. Hou,et al. Hospital-acquired renal insufficiency. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[19] W. Renner,et al. NADH/NADPH oxidase p22 phox C242T polymorphism and lipid peroxidation in coronary artery disease. , 2001, Clinical physiology.
[20] U. de Faire,et al. Oxidative stress, human genetic variation, and disease. , 2001, Archives of biochemistry and biophysics.
[21] U. de Faire,et al. A common functional C-T substitution polymorphism in the promoter region of the human catalase gene influences transcription factor binding, reporter gene transcription and is correlated to blood catalase levels. , 2001, Free radical biology & medicine.
[22] G. FitzGerald,et al. Twenty-first century phox: not yet ready for widespread screening. , 2001, Circulation.
[23] K. Channon,et al. Functional Effect of the C242T Polymorphism in the NAD(P)H Oxidase p22phox Gene on Vascular Superoxide Production in Atherosclerosis , 2000, Circulation.
[24] M. Fischer,et al. Impact of acute renal failure on antioxidant status in multiple organ failure , 2000, Acta anaesthesiologica Scandinavica.
[25] Y. Hayashi,et al. Expression of NADH/NADPH oxidase p22phox in human coronary arteries. , 1999, Circulation.
[26] R. Crystal,et al. Gene therapy for oxidant injury-related diseases: adenovirus-mediated transfer of superoxide dismutase and catalase cDNAs protects against hyperoxia but not against ischemia-reperfusion lung injury. , 1998, Human gene therapy.
[27] R. Apsner,et al. Fat-Soluble Vitamins in Patients with Acute Renal Failure , 1998, Mineral and Electrolyte Metabolism.
[28] K. Kanazawa,et al. Polymorphism of the NADH/NADPH oxidase p22 phox gene in patients with coronary artery disease. , 1998, Circulation.
[29] Sudhir V. Shah,et al. Oxidant mechanisms in toxic acute renal failure. , 1997, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[30] J. Beckman. Oxidative damage and tyrosine nitration from peroxynitrite. , 1996, Chemical research in toxicology.
[31] J. Hayes,et al. Potential contribution of the glutathione S-transferase supergene family to resistance to oxidative stress. , 1995, Free radical research.
[32] W. Knaus,et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. , 1992, Chest.
[33] J. E. Carceller. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis , 1992, Critical care medicine.
[34] W. Knaus,et al. Multiple systems organ failure: epidemiology and prognosis. , 1989, Critical care clinics.
[35] E. Draper,et al. APACHE II: A severity of disease classification system , 1985, Critical care medicine.
[36] P. Rousseeuw. Least Median of Squares Regression , 1984 .
[37] J. Cohen,et al. Hospital-acquired renal insufficiency: a prospective study. , 1983, The American journal of medicine.
[38] G. Berti,et al. Use of 3,5-dichloro-2-hydroxybenzenesulfonic acid/4-aminophenazone chromogenic system in direct enzymic assay of uric acid in serum and urine. , 1980, Clinical chemistry.
[39] B. Jaber,et al. Polymorphism of host response genes: implications in the pathogenesis and treatment of acute renal failure. , 2005, Kidney international.
[40] A. Demaine,et al. Association of the p 22 phox Component of NAD ( P ) H Oxidase With Susceptibility to Diabetic Nephropathy in Patients With Type 1 Diabetes , 2003 .
[41] K Doqi,et al. clinical practice guidelines for chronic kidney disease : evaluation, classification, and stratification , 2002 .
[42] J. Mitchell,et al. Redox imbalance in the critically ill. , 1999, British medical bulletin.